BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

655 related articles for article (PubMed ID: 19788770)

  • 1. Quality of life measures (EORTC QLQ-C30 and SF-36) as predictors of survival in palliative colorectal and lung cancer patients.
    Grande GE; Farquhar MC; Barclay SI; Todd CJ
    Palliat Support Care; 2009 Sep; 7(3):289-97. PubMed ID: 19788770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting SF-6D from the European Organization for Treatment and Research of Cancer Quality of Life Questionnaire scores in patients with colorectal cancer.
    Wong CK; Lam CL; Wan YF; Rowen D
    Value Health; 2013; 16(2):373-84. PubMed ID: 23538190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The assessment of health-related quality of life and related factors in Chinese elderly patients undergoing chemotherapy for advanced cancer: a cross-sectional study.
    Li Q; Lin Y; Qiu Y; Gao B; Xu Y
    Eur J Oncol Nurs; 2014 Aug; 18(4):425-35. PubMed ID: 24721179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Health-related quality of life in colorectal cancer.
    Färkkilä N; Sintonen H; Saarto T; Järvinen H; Hänninen J; Taari K; Roine RP
    Colorectal Dis; 2013 May; 15(5):e215-22. PubMed ID: 23351057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Health-related quality of life in patients with lung cancer: validation of the Mexican-Spanish version and association with prognosis of the EORTC QLQ-LC13 questionnaire.
    Arrieta Ó; Núñez-Valencia C; Reynoso-Erazo L; Alvarado S; Flores-Estrada D; Angulo LP; Oñate-Ocaña LF
    Lung Cancer; 2012 Jul; 77(1):205-11. PubMed ID: 22387006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A global analysis of multitrial data investigating quality of life and symptoms as prognostic factors for survival in different tumor sites.
    Quinten C; Martinelli F; Coens C; Sprangers MA; Ringash J; Gotay C; Bjordal K; Greimel E; Reeve BB; Maringwa J; Ediebah DE; Zikos E; King MT; Osoba D; Taphoorn MJ; Flechtner H; Schmucker-Von Koch J; Weis J; Bottomley A;
    Cancer; 2014 Jan; 120(2):302-11. PubMed ID: 24127333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic values of EORTC QLQ-C30 and QLQ-HCC18 index-scores in patients with hepatocellular carcinoma - clinical application of health-related quality-of-life data.
    Li L; Mo FK; Chan SL; Hui EP; Tang NS; Koh J; Leung LK; Poon AN; Hui J; Chu CM; Lee KF; Ma BB; Lai PB; Chan AT; Yu SC; Yeo W
    BMC Cancer; 2017 Jan; 17(1):8. PubMed ID: 28052758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health-related quality of life in advanced non-small cell lung cancer: correlates and comparisons to normative data.
    Larsson M; Ljung L; Johansson BB
    Eur J Cancer Care (Engl); 2012 Sep; 21(5):642-9. PubMed ID: 22519874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Health-related quality of life in disease-free survivors of surgically treated lung cancer compared with the general population.
    Yun YH; Kim YA; Min YH; Chang YJ; Lee J; Kim MS; Lee HS; Kim J; Choi YS; Shim YM; Zo JI
    Ann Surg; 2012 May; 255(5):1000-7. PubMed ID: 22470076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is it useful to calculate sum scores of the quality of life questionnaire EORTC QLQ-C30?
    Hinz A; Einenkel J; Briest S; Stolzenburg JU; Papsdorf K; Singer S
    Eur J Cancer Care (Engl); 2012 Sep; 21(5):677-83. PubMed ID: 22624663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cross-cultural verification of the EORTC QLQ-C15-PAL questionnaire in mainland China.
    Zhang L; Wang N; Zhang J; Liu J; Luo Z; Sun W; Woo SM; Chen C; Zhang K; Miller AR; Guo H; Zhang X; Wang C
    Palliat Med; 2016 Apr; 30(4):401-8. PubMed ID: 26121985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychometric validation of the Moroccan version of the EORTC QLQ-C30 in colorectal Cancer patients: cross-sectional study and systematic literature review.
    El Alami Y; Essangri H; Majbar MA; Boutayeb S; Benamr S; El Malki HO; Souadka A
    BMC Cancer; 2021 Jan; 21(1):99. PubMed ID: 33499819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does palliative chemotherapy really palliate and are we measuring it correctly? A mixed methods longitudinal study of health related quality of life in advanced soft tissue sarcoma.
    Gough N; Koffman J; Ross JR; Riley J; Judson I
    PLoS One; 2019; 14(9):e0210731. PubMed ID: 31557183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EORTC QLQ-C30 and FACT-Lym for the assessment of health-related quality of life of newly diagnosed lymphoma patients undergoing chemotherapy.
    Georgakopoulos A; Kontodimopoulos N; Chatziioannou S; Niakas D
    Eur J Oncol Nurs; 2013 Dec; 17(6):849-55. PubMed ID: 23850411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Influence of laparoscopic or conventional colorectal resection on postoperative quality of life].
    Schwenk W; Böhm B; Müller JM
    Zentralbl Chir; 1998; 123(5):483-90. PubMed ID: 22462215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive factors of overall well-being using the EORTC QLQ-C15-PAL extracted from the EORTC QLQ-C30.
    Lam K; Zeng L; Zhang L; Tseng LM; Hou MF; Fairchild A; Vassiliou V; Jesus-Garcia R; Alm El-Din MA; Kumar A; Forges F; Chie WC; Sahgal A; Poon M; Chow E
    J Palliat Med; 2013 Apr; 16(4):402-8. PubMed ID: 23458649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between changes in quality of life scores and survival in non-small cell lung cancer patients.
    Gupta D; Braun DP; Staren ED
    Eur J Cancer Care (Engl); 2012 Sep; 21(5):614-22. PubMed ID: 22309434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The EORTC QLQ-C30 Summary Score as Prognostic Factor for Survival of Patients with Cancer in the "Real-World": Results from the Population-Based PROFILES Registry.
    Husson O; de Rooij BH; Kieffer J; Oerlemans S; Mols F; Aaronson NK; van der Graaf WTA; van de Poll-Franse LV
    Oncologist; 2020 Apr; 25(4):e722-e732. PubMed ID: 32297435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Health-related quality of life and disease specific symptoms in long-term thyroid cancer survivors: a study from the population-based PROFILES registry.
    Husson O; Haak HR; Buffart LM; Nieuwlaat WA; Oranje WA; Mols F; Kuijpens JL; Coebergh JW; van de Poll-Franse LV
    Acta Oncol; 2013 Feb; 52(2):249-58. PubMed ID: 23181387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role functioning before start of adjuvant treatment was an independent prognostic factor for survival and time to failure. A report from the Nordic adjuvant interferon trial for patients with high-risk melanoma.
    Brandberg Y; Johansson H; Aamdal S; Bastholt L; Hernberg M; Stierner U; von der Maase H; Hansson J;
    Acta Oncol; 2013 Aug; 52(6):1086-93. PubMed ID: 23621752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.